about
Understanding detrusor sphincter dyssynergia--significance of chronologyRegulation of male fertility by the bone-derived hormone osteocalcin[Treatment of detrusor-striated sphincter dyssynergia with permanent nitinol urethral stent: results after a minimum follow-up of 2 years].Review of the Different Treatments and Management for Prostate Cancer and Fertility.[Lower urinary tract dysfunctions in parkinsonian syndromes: a review by the Neuro-Urology Comittee of the French Association of Urology].[Comparative study of radical prostatectomy versus external beam radiotherapy (75.6 Gy) combined with hormone therapy for prostate cancer of intermediate D'Amico risk classification].[Hormonal treatment in prostate cancer].[The non-hormonal treatment of metastatic prostate cancer].[Chemotherapy in male external genital organs (testicular and penile cancer)].Successful pregnancies and healthy live births using frozen-thawed sperm retrieved by a new modified Hotchkiss procedure in males with retrograde ejaculation: first case series.[The impact of mellitus diabetes on the lower urinary tract: A review of Neuro-urology Committee of the French Association of Urology].Injection of botulinum toxin type A in the urethral sphincter to treat lower urinary tract dysfunction: a review of indications, techniques and results.Botulinum toxin A (Botox) intradetrusor injections in adults with neurogenic detrusor overactivity/neurogenic overactive bladder: a systematic literature review.Recommendations on the use of botulinum toxin in the treatment of lower urinary tract disorders and pelvic floor dysfunctions: a European consensus report.Botulinum toxin-A (Botox) intradetrusor injections in children with neurogenic detrusor overactivity/neurogenic overactive bladder: a systematic literature review.Injection of botulinum toxin type A in the urethral sphincter to treat lower urinary tract dysfunction: review of indications, techniques and results: 2011 update.Technical aspects of botulinum toxin type A injection in the bladder to treat urinary incontinence: reviewing the procedure.Tibial Nerve Stimulation for Treating Neurogenic Lower Urinary Tract Dysfunction: A Systematic Review.Early results and complications of prostatic arterial embolization for benign prostatic hyperplasia.Heterogeneity in reporting on urinary outcome and cure after surgical interventions for stress urinary incontinence in adult neuro-urological patients: A systematic review.A Quality Assessment of Patient-Reported Outcome Measures for Sexual Function in Neurologic Patients Using the Consensus-based Standards for the Selection of Health Measurement Instruments Checklist: A Systematic Review.Transcutaneous Electrical Nerve Stimulation for Treating Neurogenic Lower Urinary Tract Dysfunction: A Systematic Review.Switch to Abobotulinum toxin A may be useful in the treatment of neurogenic detrusor overactivity when intradetrusor injections of Onabotulinum toxin A failed.Postural therapy for renal stones in children: A Rolling Stones procedure.Long-term effectiveness and complication rates of bladder augmentation in patients with neurogenic bladder dysfunction: A systematic review.Continent catheterizable tubes/stomas in adult neuro-urological patients: A systematic review.The prognostic value of the neutrophil-lymphocyte ratio in renal oncology: A review.Involvement of connexins 43 and 45 in functional mechanism of human detrusor overactivity in neurogenic bladder.What is the outcome of paediatric gastrocystoplasty when the patients reach adulthood?Histological and Urodynamic Effects of Autologous Stromal Vascular Fraction Extracted from Fat Tissue with Minimal Ex Vivo Manipulation in a Porcine Model of Intrinsic Sphincter Deficiency.Impact of laparoscopy simulator training on the technical skills of future surgeons in the operating room: a prospective study.Efficacy and safety of onabotulinumtoxinA therapy are sustained over 4 years of treatment in patients with neurogenic detrusor overactivity: Final results of a long-term extension study.Summary of European Association of Urology (EAU) Guidelines on Neuro-Urology.[Idiopathic overactive bladder and BOTOX(®): Literature review].Guidelines for practical usage of botulinum toxin type A (BoNTA) for refractory idiopathic overactive bladder management: Translation of French recommendations.[Transcutaneous tibial nerve stimulation in the overactive bladder syndrome in patients with Parkinson's syndromes].Botulinum toxin type A inhibits the growth of LNCaP human prostate cancer cells in vitro and in vivo.[Epidemiology, etiology and psychosocial impact of urogenital fistulas in a cohort of 170 consecutive patients managed in three treatment centers in Burkina Faso from 2010 to 2012].[Epidemiology of a cohort of 450 urolithiasis at the Yalgado Ouédraogo university hospital of Ouagadougou (Burkina Faso)].[Medical treatment of bladder carcinoma].
P50
Q28277435-C1920325-438F-4EF0-B92C-FB3916CCDB6BQ28300656-4376D2A7-C6D5-4CE8-A6EB-5677EF2F801BQ34488867-7EB95AD9-8288-4973-A6C8-CE325BD45691Q34494054-4FE2E3A6-4A6A-4897-A5C2-EFBAD3F54FAAQ34643293-23DDA565-6359-45BE-A7DF-98610F53F8D0Q34987027-68152D65-E841-472A-8ACB-1F9415BE5A31Q35030688-AA82F1C4-030F-471C-A12A-DB03A5B5ABB4Q35030692-35A334FC-A6AC-4EF3-AD52-D46CCB8D8CC6Q35030696-FB5B2146-43C7-479F-92AD-4C96A42A84E6Q35670474-2512813B-2285-4F45-BE15-DBB68F16CB95Q35802102-F65F1B7E-6ABC-424F-B5A3-9652C2437A31Q36467482-DF1AE36D-5B3A-452A-8AA9-03C25B94FE6FQ36995681-78535E1B-B008-45DE-B34E-69903CC7777AQ37281713-E56E6946-034F-45CF-8318-42881AAE0F02Q37407525-8391ED93-C026-4363-B4A0-E30A22C653DDQ37920004-A0011BA4-C09C-4868-B320-06DEE75B5C01Q38182708-B2A5DD8B-7047-4819-A1EB-0D8C0FFBE469Q38550906-832A1171-7748-416D-8BC5-00043F2723C3Q38567164-B377BABF-3F81-4362-8A2C-F49E0C588FF5Q38644974-F6AC80BF-13F3-43F6-80F2-9B734AC0660BQ38650307-F5EBEFCD-D5E5-46AC-B36F-85C301D90A5AQ38718434-D2DF68C3-AA16-49D0-89E7-996160C4E02CQ38826378-5556BE86-FA4E-4E7F-9BC3-59829CC21092Q38872312-60FCE376-C8D1-4FA7-B817-B53D3E56AFC8Q38974505-9A541802-C096-4AA5-B64E-51C8D7E86AE1Q38989987-0118C583-16CF-4928-8010-02E6A84BE0FEQ39149165-6DA0F05E-620C-48E8-BC8D-80A527AFC7CFQ39451719-B9ED66FE-9C33-475B-A50B-5182FE875C4FQ39670311-93952F4F-42F5-4273-B4CE-83FC97D8E774Q39707911-C4800030-F782-46FA-B336-045301CF6C72Q39741005-A84150C4-776A-4C9F-A94F-B02D9EC77B37Q40274618-F7C21B86-6A91-4A41-AE18-0D90A191A8ECQ41035239-1756B56D-4D5F-400B-A931-365BAD9C96ACQ41495570-211BE96C-E64D-48F1-8069-5708E654926BQ41741859-878F2718-7ADE-4598-90AF-92A16849A06FQ43503034-6001C892-CFD1-49F7-ACE7-6EAD1F62491EQ43549043-175D0BE4-9DD0-4CA7-B6C0-EA5B728A0CB8Q43927526-DCD0512A-6A47-4D68-BF5E-D6D8E88E846BQ43928137-3113C08C-A2D5-4D1B-9F64-66AB5CC4C20DQ44538690-DA6403CD-A5D8-4351-A13B-DDBDB857E083
P50
description
researcher ORCID ID = 0000-0002-9047-3332
@en
wetenschapper
@nl
name
Gilles Karsenty
@ast
Gilles Karsenty
@en
Gilles Karsenty
@es
Gilles Karsenty
@nl
type
label
Gilles Karsenty
@ast
Gilles Karsenty
@en
Gilles Karsenty
@es
Gilles Karsenty
@nl
prefLabel
Gilles Karsenty
@ast
Gilles Karsenty
@en
Gilles Karsenty
@es
Gilles Karsenty
@nl
P106
P31
P496
0000-0002-9047-3332